CeeMCee Pharma Consulting

CeeMCee Pharma Consulting has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €237,984 and a net result of €62,418. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 75% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).